Melphalan (Alvogen Inc.)
Welcome to the PulseAid listing for the Melphalan drug offered from Alvogen Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Alvogen Inc. |
| NON-PROPRIETARY NAME: | Melphalan USP, 2 mg |
| SUBSTANCE NAME: | MELPHALAN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-03-22 |
| END MARKETING DATE: | 0000-00-00 |
Melphalan HUMAN PRESCRIPTION DRUG Details:
| Item Description | Melphalan from Alvogen Inc. |
| LABELER NAME: | Alvogen Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/1) |
| START MARKETING DATE: | 2017-03-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 47781-200_8cbb7338-0bf3-0df7-5e77-641bbca6cf32 |
| PRODUCT NDC: | 47781-200 |
| APPLICATION NUMBER: | ANDA207809 |
Other MELPHALAN Pharmaceutical Manufacturers / Labelers:
